Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Joseph D. Armstrong"'
Autor:
Grace P. Ahlqvist, Catherine P. McGeough, Chris Senanayake, Joseph D. Armstrong, Ajay Yadaw, Sarabindu Roy, Saeed Ahmad, David R. Snead, Timothy F. Jamison
Publikováno v:
ACS Omega, Vol 6, Iss 15, Pp 10396-10402 (2021)
Externí odkaz:
https://doaj.org/article/e106909195e0497984dd6bd8942615f4
Autor:
Sarabindu Roy, Ajay Yadaw, Subho Roy, Gopal Sirasani, Aravind Gangu, Jack D. Brown, Joseph D. Armstrong, Rodger W. Stringham, B. Frank Gupton, Chris H. Senanayake, David R. Snead
Publikováno v:
Organic Process Research & Development
Pyrrolo[2,1-f][1,2,4]triazine (1) is an important regulatory starting material in the production of the antiviral drug remdesivir. Compound 1 was produced through a newly developed synthetic methodology utilizing simple building blocks such as pyrrol
Autor:
Ajay Yadaw, Saeed Ahmad, Grace P. Ahlqvist, Joseph D. Armstrong, Sarabindu Roy, Chris H. Senanayake, Catherine P. McGeough, Timothy F. Jamison, David R. Snead
Publikováno v:
ACS Omega, Vol 6, Iss 15, Pp 10396-10402 (2021)
ACS Omega
ACS Omega
Molnupiravir (MK-4482, EIDD-2801) is a promising orally bioavailable drug candidate for the treatment of COVID-19. Herein, we describe a supply-centered and chromatography-free synthesis of molnupiravir from cytidine, consisting of two steps: a selec
Autor:
Joseph D. Armstrong, Sarabindu Roy, Ajay Yadaw, Chris H. Senanayake, B. Frank Gupton, Gopal Sirasani, Subho Roy, David R. Snead
Pyrrolo[2,1-f][1,2,4]triazine (1) is an important regulatory starting material in the production of Remdesivir (Veklury®). Compound 1 was produced through a newly developed synthetic methodology utilizing the simple building blocks pyrrole, chlorami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1255dd5b9e457664fde4c686f78ead6f
https://doi.org/10.26434/chemrxiv.14109650.v1
https://doi.org/10.26434/chemrxiv.14109650.v1
Autor:
Tim Jamison, David R. Snead, Saeed Ahmad, Sarabindu Roy, Ajay Yadaw, Joseph D. Armstrong, Chris Senanayake, Catherine P. McGeough, Grace P. Ahlqvist
Molnupiravir (MK-4482, EIDD-2801) is a promising orally bioavailable drug candidate for treatment of COVID-19. Herein we describe a supply-centered and chromatography-free synthesis of molnupiravir from cytidine, consisting of two steps: a selective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d030c7fd413a5fb633332565ceb7bfd
https://doi.org/10.26434/chemrxiv.13809527.v1
https://doi.org/10.26434/chemrxiv.13809527.v1
Autor:
Jaume Balsells, Edward J. J. Grabowski, Shane W. Krska, Nelo R. Rivera, Yongkui Sun, Joseph D. Armstrong, Bryon Simmons, Andrew M. Clausen, Felix Spindler, Yi Hsiao, Michele Kubryk, Christophe Malan, Karl B. Hansen, Nori Ikemoto, Feng Xu, Thorsten Rosner
Publikováno v:
Journal of the American Chemical Society. 142:13622-13622
Autor:
Edward C. Sherer, Zhen Li, Daniel Zewge, Gabor Butora, Ian W. Davies, Joseph D. Armstrong, Greg Copeland, David M. Tellers, Joseph R. Gouker, Daniel R. Sidler, Vasant Jadhav
Publikováno v:
Bioconjugate chemistry. 29(6)
An efficient multicomponent orthogonal protocol was developed for post-synthetic oligonucleotide modification using commercially available 2'- O-methyl ester and 2'- O-propargyl nucleoside scaffolds. Amidation of methyl esters with primary amines was
Publikováno v:
The Journal of Organic Chemistry. 71:840-843
[reaction: see text] Very practical synthesis of ephedrine analogues in high yields and enantiopurity was realized by a highly diastereoselective Meerwein-Ponndorf-Verley (MPV) reduction of protected alpha-amino aromatic ketones using catalytic alumi
Publikováno v:
Organic Letters. 7:4935-4938
[reaction: see text] The catalytic asymmetric hydrogenation of enamine amides and esters with catalyst Rh-1a, prepared from ferrocenyl based ligand 1a or 1b and [(COD)RhCl](2), has been shown through kinetic studies to suffer from product inhibition.
Autor:
Karl B. Hansen, Jaume Balsells, David Askin, Yi Hsiao, Nelo R. Rivera, Dietrich Steinhuebel, Edward J. J. Grabowski, Joseph D. Armstrong, Spencer D. Dreher, Michele Kubryk, Michael Palucki
Publikováno v:
Organic Process Research & Development. 9:634-639
A new synthesis of sitagliptin (MK-0431), a DPP-IV inhibitor and potential new treatment for type II diabetes, suitable for the preparation of multi-kilogram quantities is presented. The triazolopyrazine fragment of sitagliptin was prepared in 26% yi